
Cancer zzso trials have unique characteristics that make the tasks of participant zzso enrollment, and long-term adherence to the study protocol and intervention regimen especially zzso zzso to patient zzso long-term zzso and optimal adherence are inherent in clinical trial design and organization, and are frequently associated with the attitudes and behavioral dynamics of physicians and the participants zzso zzso racially and ethnically diverse populations to trial participation adds additional problems and zzso zzso planning early in the design phase of a zzso clinical trial must take into account these numerous zzso Clinical investigators should seek expert advice from a number of health care disciplines to better design zzso protocols that minimize zzso complexity, maximize participant zzso simplify data collection, and take into account the complex behavioral dynamics of the clinical trial zzso 

